Investor Stock List
Ranked #1,703 of 8,699 institutional investors

Fairmount Funds Management LLC

West Conshohocken, PA

$1.68B
US stock portfolio at live prices · today +$32.0M (+1.94%)
Market closed. Prices as of Nov 20, 8:41 AM ET
Value at quarter end (Q3 2026)
$1.59B
Change from Q2 2026
+$81.6M (+5.39%)
Positions
10 · 1 new, 0 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$238M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
ORKA 21.5%KRSA 19.2%DNTH 12.8%VRDN 9.52%COGT 9.08%
StockSharesValue, live% of portfoliovs Q2 2026
ORKA Oruka Therapeutics, Inc.3,705,262$362M21.5%Unchanged
KRSA Korsana Biosciences, Inc.9,103,729$323M19.2%New
DNTH Dianthus Therapeutics, Inc.2,537,191$215M12.8%Unchanged
VRDN Viridian Therapeutics, Inc.5,090,928$160M9.52%Unchanged
COGT Cogent Biosciences, Inc.5,503,418$153M9.08%Unchanged
ELVN Enliven Therapeutics, Inc.1,855,644$86.1M5.12%Unchanged
JBIO Jade Biosciences, Inc.4,553,494$68.6M4.08%Unchanged
ZBIO Zenas BioPharma, Inc.2,371,358$59.4M3.53%Added +1%
IKT Inhibikase Therapeutics, Inc.8,625,000$11.2M0.67%Unchanged
FTH Faeth Therapeutics, Inc.722,020$6.3M0.37%Unchanged